Core A: Lipidomics
Core A: Lipidomics
批准号:
9072009
负责人:
ALICJA BIELAWSKA
金额:
$26.6万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2021-04-30
关键词:
Antineoplastic AgentsApoptosisBiocompatible MaterialsBiologicalBiological AssayBiologyBlood specimenBrainCancer BiologyCancer CenterCell Culture TechniquesCell DeathCellsCeramidaseCeramidesChemicalsCoupledCulture MediaDataData AnalysesDevelopmentDrug TargetingDrug or chemical Tissue DistributionEducational workshopEnzyme Inhibitor DrugsEnzyme InhibitorsEnzymesExperimental DesignsFunctional disorderFutureGenerationsGoalsGrowthHigh Pressure Liquid ChromatographyHumanHuman ResourcesImageIn VitroInternationalKidneyLabelLipid ChemistryLipidsLiquid substanceLiverMalignant NeoplasmsMass Spectrum AnalysisMeasurementMeasuresMentorsMetabolicMetabolismMethodologyMethodsMolecularMolecular AnalysisMolecular ProfilingNeoplasm MetastasisNormal CellNormal tissue morphologyOrganOrganellesPathologyPathway interactionsPharmaceutical PreparationsPlasmaPreparationProceduresProtocols documentationRadioactiveRadiolabeledReagentRegulationResearchResearch PersonnelResource SharingResourcesRoleSerumServicesSignal TransductionSiteSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSphingolipidsSphingomyelinaseSphingomyelinsStereoisomerStructureTechnologyTherapeuticTissuesTrainingVertebral columnWorkanalogangiogenesisbasebiobankcancer cellcancer therapycomparativedesigndihydroceramidedrug distributionenzyme activityin vitro activityin vivoinhibitor/antagonistinorganic phosphateinterestlipid mediatorlipid metabolismliquid chromatography mass spectrometrymetabolomicsnovelprogramsradiotracerresearch studyresponsetandem mass spectrometrytherapeutic targettissue preparationtooltumortumor progressiontumor xenograft
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
The purpose of the Lipidomics Core in the PPG is to provide intellectual and physical resources (particularly
state-of-the-art mass spectrometry analysis of sphingolipids and synthetic molecular tools) to enhance
understanding of the role of bioactive lipids in cancer biology with the goal to discover future therapeutics. The
diversity of bioactive lipids and their interconnected metabolism generates a network of pathways regulating
intra- and inter-cellular signaling and function. Dysfunctions in these pathways contribute to the pathobiology of
cancer progression and metastasis. These considerations have necessitated the development of lipid
chemistry and analysis. The Lipidomics Core was created based on unique expertise of the key personnel in
lipid chemistry, analysis, and metabolism. This Core has developed into an institutional, national, and
international resource in the emerging fields of lipidomics and lipid chemical biology. Core services include: 1)
Providing qualitative and quantitative analysis of lipid components from different biological materials (cells,
tissue, and biological fluids), primarily employing high performance liquid chromatography-tandem mass
spectrometry (HPLC-MS/MS) technology—the Core currently provides quantitative analysis of more than 300
distinct lipid molecular species at a basic metabolomic level; 2) Developing and providing synthetic molecular
tools to study lipid metabolism (e.g., functionalized and fluorescent ceramides, site-specific radioactive
sphingolipids, 17C-sphingolipids) and diversified synthetic lipids and analogs for cellular, in vitro, and in vivo
studies (e.g., organelle-targeted sphingolipids and organelle-targeted inhibitors of sphingolipid metabolizing
enzymes); 3) Providing direct MALDI-MS tissue analysis to visualize the distribution of lipid based anti-cancer
drugs and their molecular effects on sphingolipid components; and 4) Assisting PPG investigators in
experimental design, selection of lipids of interest, and interpretation of analytical results.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SC COBRE: LIPIDOMICS CORE
-
批准号:8360378
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2011
-
负责人:ALICJA BIELAWSKA
-
依托单位:
SC COBRE: LIPIDOMICS CORE
-
批准号:8168043
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2010
-
负责人:ALICJA BIELAWSKA
-
依托单位:
SC COBRE: LIPIDOMICS CORE
-
批准号:7959962
-
项目类别:
-
资助金额:$43.8万
-
财政年份:2009
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Lipidomics Shared Resource
-
批准号:7944514
-
项目类别:
-
资助金额:$7.26万
-
财政年份:2009
-
负责人:ALICJA BIELAWSKA
-
依托单位:
SC COBRE: LIPIDOMICS CORE
-
批准号:7720843
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2008
-
负责人:ALICJA BIELAWSKA
-
依托单位:
SC COBRE: LIPIDOMICS CORE
-
批准号:7610438
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2007
-
负责人:ALICJA BIELAWSKA
-
依托单位:
SC COBRE: LIPIDOMICS CORE
-
批准号:7381843
-
项目类别:
-
资助金额:$38.71万
-
财政年份:2006
-
负责人:ALICJA BIELAWSKA
-
依托单位:
SC COBRE: LIPIDOMICS CORE
-
批准号:7171073
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2005
-
负责人:ALICJA BIELAWSKA
-
依托单位:
CORE--LIPIDOMICS
-
批准号:6981756
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2004
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Lipidomics Core
-
批准号:8308980
-
项目类别:
-
资助金额:$19.24万
-
财政年份:2003
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Core B: Lipidomics Core(Consortium)
-
批准号:8742657
-
项目类别:
-
资助金额:$17.05万
-
财政年份:2003
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Core B: Lipidomics Core(Consortium)
-
批准号:9130748
-
项目类别:
-
资助金额:$17.12万
-
财政年份:2003
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Core B: Lipidomics Core(Consortium)
-
批准号:8936017
-
项目类别:
-
资助金额:$17.05万
-
财政年份:2003
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Core B: Lipidomics Core(Consortium)
-
批准号:9337351
-
项目类别:
-
资助金额:$17.09万
-
财政年份:2003
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Lipidomics Core
-
批准号:7879398
-
项目类别:
-
资助金额:$20.06万
-
财政年份:2003
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Lipidomics Core
-
批准号:8381034
-
项目类别:
-
资助金额:$20.03万
-
财政年份:2003
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Lipidomics Core
-
批准号:8131772
-
项目类别:
-
资助金额:$20.51万
-
财政年份:2003
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Lipidomics Core
-
批准号:7534144
-
项目类别:
-
资助金额:$12.8万
-
财政年份:2003
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Lipidomics Shared Resource
-
批准号:8072099
-
项目类别:
-
资助金额:$7.78万
-
财政年份:--
-
负责人:ALICJA BIELAWSKA
-
依托单位:
Core A: Lipidomics
-
批准号:9980700
-
项目类别:
-
资助金额:$25.81万
-
财政年份:--
-
负责人:ALICJA BIELAWSKA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: